Integrated management of multidrug-resistant tuberculosis, HIV, and hepatitis B co-infection in Ghana: a case report - Summary - MDSpire

Integrated management of multidrug-resistant tuberculosis, HIV, and hepatitis B co-infection in Ghana: a case report

  • By

  • Stanley Yaidoo

  • Judith Maame Tanoa Yelbert

  • Rodger MacScott-Lutterodt

  • Elizabeth Nkumah Obeng

  • Stephannie Kafui Amenya

  • June 15, 2026

  • 0 min

Share

Objective:

To present a case study highlighting the complexities of managing co-infection with MDR-TB, HIV, and hepatitis B in a resource-limited setting, emphasizing the systemic health challenges faced.

Approach:
    Key Findings:
    • The patient completed a 12-month MDR-TB regimen with documented microbiological cure.
    • Ongoing antiretroviral therapy for HIV was maintained.
    • Chronic hepatitis B and renal disease were monitored without specific antiviral treatment due to cost constraints.
    Interpretation:

    Omit unsupported claims.

    Limitations:
    • Routine HBV screening among HIV-positive patients is not widely implemented in Ghana.
    • Cost of managing chronic HBV infection is prohibitive for most patients.
    Conclusion:

    Omit unsupported claims.

Original Source(s)

Related Content